FDA Creates New Webpages to Address Defective Hips

The FDA has created a new section on its website devoted to artificial hips including sections about the potential adverse effects of metal-on-metal hip replacement devices. The new information comes after many months of consumer concern about the DePuy ASR hip recall. DePuy hip lawsuits are mounting as more consumers are becoming aware of adverse effects concerning their hip replacements. Such adverse effects include joint discomfort, joint swelling, tissue necrosis, and metallosis. The FDA devoted a substantial section to metallosis which is essentially metal poisoning resulting from the metal-on-metal hip device releasing chromium and cobalt into the bloodstream. The release of these metals results from the grinding of the metal hip parts against one another. Metallosis is a particularly dangerous condition since it can go undetected and the patient may have little or no symptoms. A special blood test may be administered to determine if the hip implant is causing such a condition.
DePuy hip lawsuits have been filed against the manufacturer since the August 2010 recall of the DePuy ASR XL Acetabular Systems. The recall was initiated after it was determined that the DePuy ASR hips were failing at an unacceptable rate within the first five years of implantation. The failure rate has been estimated to be around 12-13% of implanted DePuy hips. These hip failures have led to many patients having to undergo painful and difficult revision surgeries.